Bryn Mawr Trust CO Rocket Pharmaceuticals, Inc. Transaction History
Bryn Mawr Trust CO
- $5.88 Billion
- Q3 2025
A detailed history of Bryn Mawr Trust CO transactions in Rocket Pharmaceuticals, Inc. stock. As of the latest transaction made, Bryn Mawr Trust CO holds 140 shares of RCKT stock, worth $518. This represents 0.0% of its overall portfolio holdings.
Number of Shares
140Holding current value
$518% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding RCKT
# of Institutions
218Shares Held
98.3MCall Options Held
608KPut Options Held
474K-
Rtw Investments, LP New York, NY17.7MShares$65.4 Million0.67% of portfolio
-
Lee Ainslie Maverick Capital LTD | Dallas, Tx8.36MShares$30.9 Million0.35% of portfolio
-
Black Rock Inc. New York, NY6.19MShares$22.9 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.12MShares$22.7 Million0.0% of portfolio
-
Westfield Capital Management CO LP Boston, MA4.82MShares$17.8 Million0.17% of portfolio
About ROCKET PHARMACEUTICALS, INC.
- Ticker RCKT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 75,683,696
- Market Cap $280M
- Description
- Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...